You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 5, May 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Off-Center Fold
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Neoplasms
 •Diagnosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Slowly Enlarging, Unilateral, Erythematous Macular Lesion—Diagnosis

Arch Dermatol. 2006;142:641-646.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Unilateral telangiectasia macularis eruptiva perstans (TMEP).

MICROSCOPIC FINDINGS AND CLINICAL COURSE

The lesional biopsy specimen, which was compared with one from unaffected skin, revealed dilated upper dermal vessels with a discrete perivascular cellular infiltrate with increased mast cell numbers (range, 10-20 per high-power field) on Giemsa staining. Routine blood tests (including serum tryptase levels), abdominal ultrasound, and bone scintigraphy revealed no abnormalities. There were significant increases in the 24-hour urinary excretion of N-methylhistamine (355 µg [reference value, <172 µg]) and 1-methyl-4-imidazoleacetic acid (27.3 mg [reference value, <4.5 mg]). The overall picture was consistent with TMEP with a unilateral distribution.

Treatment was symptomatic. The patient was advised to avoid the specific triggers that might stimulate mast cell degranulation. H1 antihistamines were administered to provide relief of flushing (ebastine, 20 mg/d, plus hydroxyzine hydrochloride, 50 mg/d). After 2 years of follow-up, there were no signs of systemic involvement.

DISCUSSION

Mastocytosis is a rare disease that is characterized by a primary pathologic increase in . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.